|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Ixabepilone,first in a new class of antineoplastic agents:the natural epothilones and their analogues显示文摘 | Fornier M | 2007 | Clin Breast Cancer2007，7，10： | 1 |
| 2 | Tumor markers CEA,NSE,SCC,TPA and CYFRA21-1 in resectable non-small cell lung cancer显示文摘 | Foa P Fornier M Miceli R | 1999 | Anticancer Res1999，19，4： | 1 |
| 3 | Serum HER-2/neu change predicts clinical outcome to trastuzumab-based therapy显示文摘 | Ali SM Esteva FJ Fornier M | | 0，，18： | 1 |
| 4 | A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer显示文摘 | Fornier MN Morris PG Abbruzzi A | 2011 | Ann Oncol2011，22，12： | 1 |
| 5 | Phase Ⅱ clinical trial of ixabepilone(BMS-247550),an epothilone B analog,in patients with taxane-resistant metastatic breast cancer显示文摘 | Thomas E Tabernero J Fornier M | 2007 | J Clin Oncol2007，25，23： | 1 |
| 6 | Tumour markers CEA,NSE,SCC,TPA and CYFRA211 in respectable not small cell lung cancer显示文摘 | Foa P Fornier M Miceli R | 1999 | Anticancer Res1999，19，4： | 1 |
| 7 | Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer显示文摘 | Esteva FJ Seidman AD | 2000 | Semin Oncol2000，27，611： | 1 |
| 8 | Incidence of chemotherapy-induced,long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane显示文摘 | FORNIER M N MODI S PANAGEAS K S | | 0，，08： | 1 |
| 9 | Final report: weekly herceptin and taxol for metastatic breast cancer: analysis of efficacy by HER-2 immunophenotype and gene amplification 显示文摘 | Fornier M Esteva F | 2000 | Proc Am Soc Clin Oncol2000，19，： | 1 |
| 10 | Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer显示文摘 | Fornier M Esteva FJ Seidman AD | | 0，，6： | 1 |
| 11 | Current status and future potential role of exemestane in the treatment of early and advanced breast cancer 显示文摘 | Crucitta E Fornier M N Locopo N | 2002 | lnt J Oncol2002，20，6： | 1 |
| 12 | Tumor markers CEA,NSE,SCC,TPA and CYFRA21-1 in respectable non-small cell lung cancer显示文摘 | Foa P Fornier M Miceli R | 1999 | Anticancer Res1999，19，4： | 1 |
| 13 | Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification 显示文摘 | Seidman AD Fornier MN Esteva FJ | 2001 | J Clin Oncol2001，19，： | 1 |
| 14 | Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer显示文摘 | Fornier M Esteva FJ Seidman AD | 2000 | Semin Oncol2000，27，1： | 1 |
| 15 | Tumourmarkers CEA, NSE,SCC, TPA and CYFRA21-1 in respectable non- small cell lungcancer 显示文摘 | Foa P Fornier M Miceli R | 1999 | Anticancer Res1999，19，4： | 1 |
| 16 | Serum HER2 extracellular domain in metastatic breast cancer patients treated with weekly trastuzumab and paclitaxel: association with HER2 status by immunohistochemistry and fluorescence in situ hybridization and with response rate 显示文摘 | Fornier MN Seidman AD Schwartz MK | 2005 | Ann Oncol2005，16，2： | 1 |
| 17 | Incidence ofchemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane显示文摘 | Fornier M N Modi S Panageas K S | 2005 | Cancer2005，104，8： | 1 |
| 18 | Tumour markers CEA, NSE, SCC, TPA and CYFRA21 - 1 in resectable non- small cell lung cancer显示文摘 | Foa P Fornier MF Miceli R | 1999 | Anticancer - Res1999，19，： | 1 |
| 19 | Epothilones in breast cancer: review of clinical experience 显示文摘 | FORNIER MN | 2007 | Ann Oncol2007，18，5： | 1 |
| 20 | Risk models for neutropenia in patients with breast cancer 显示文摘 | Dang CT Fornier MN Hudis CA | 2003 | Ontology (Williston Park)2003，17，1111： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员